Trials / Unknown
UnknownNCT00945386
The Effect of Continuous, Various Doses of Furosemide Drip on Hearing as Measured by Acoustic Emission
The Effect of Continuous, Various Dosages of Furosemide Drip on Hearing as Measured by Acoustic Emission
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- Rabin Medical Center · Academic / Other
- Sex
- All
- Age
- 1 Month – 18 Years
- Healthy volunteers
- Not accepted
Summary
Pediatric patients, during their illness often treated with furosemide (Lasix) continuous drip, often, with dosages above 4-6mg/kg/day (the recommended dose). This study will monitor hearing status of these children prior to their therapy with furosemide, during this therapy and after.
Detailed description
This study will record hearing status, by acoustic emission, of critically ill children, treated with different dosages of furosemide drip. Acoustic emission test will be done prior to therapy and q48 hours during their course of treatment with furosemide drip. Dosage of furosemide drip, boluses and other relevant medications (i.e - vancomycin, muscular relaxants, aminoglycosides etc) will be recorded.
Conditions
Timeline
- Start date
- 2009-08-01
- Completion
- 2010-08-01
- First posted
- 2009-07-24
- Last updated
- 2009-07-24
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00945386. Inclusion in this directory is not an endorsement.